Retraction note: Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria
- PMID: 38994322
- PMCID: PMC11235437
- DOI: 10.12998/wjcc.v12.i19.4029
Retraction note: Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria
Abstract
[This retracts the article on p. 2173 in vol. 12, PMID: 38808336.].
Keywords: Retraction note; World Journal of Clinical Cases.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Retraction of
-
Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.World J Clin Cases. 2024 May 6;12(13):2173-2181. doi: 10.12998/wjcc.v12.i13.2173. World J Clin Cases. 2024. Retraction in: World J Clin Cases. 2024 Jul 6;12(19):4029-4030. doi: 10.12998/wjcc.v12.i19.4029. PMID: 38808336 Free PMC article. Retracted.
Similar articles
-
Retraction note to four articles published in World Journal of Orthopaedics.World J Orthop. 2018 Mar 18;9(3):58-59. doi: 10.5312/wjo.v9.i3.58. eCollection 2018 Mar 18. World J Orthop. 2018. PMID: 29564215 Free PMC article.
-
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16. Lancet Infect Dis. 2018. PMID: 29456043 Clinical Trial.
-
Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.World J Clin Cases. 2024 May 6;12(13):2173-2181. doi: 10.12998/wjcc.v12.i13.2173. World J Clin Cases. 2024. Retraction in: World J Clin Cases. 2024 Jul 6;12(19):4029-4030. doi: 10.12998/wjcc.v12.i19.4029. PMID: 38808336 Free PMC article. Retracted.
-
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?Expert Rev Anti Infect Ther. 2023 Apr;21(4):387-429. doi: 10.1080/14787210.2023.2184346. Epub 2023 Mar 8. Expert Rev Anti Infect Ther. 2023. PMID: 36820511 Review.
-
Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.Int J Antimicrob Agents. 2014 Dec;44(6):477-85. doi: 10.1016/j.ijantimicag.2014.07.004. Epub 2014 Aug 10. Int J Antimicrob Agents. 2014. PMID: 25199968 Review.
References
Publication types
LinkOut - more resources
Full Text Sources